Zydus Lifesciences Limited (including its subsidiaries/ affiliates, hereafter referred to as “Zydus”) has received final approval from the United States Food and Drug Administration (USFDA) to ...

Zydus Lifesciences Ltd on Wednesday said it has received final approval from the US health regulator to manufacture its generic version of Methenamine Hippurate tablets used in treatment of urinary ...

Zydus Lifesciences Limited announced today it has received final approval from the US Food and Drug Administration (USFDA) to manufacture Methenamine Hippurate Tablets USP, 1 gram. The medication ...